Cargando…
Efficacy and feasibility of stereotactic radiotherapy after folfirinox in patients with locally advanced pancreatic cancer (LAPC-1 trial)
BACKGROUND: We conducted a multicentre phase II trial to investigate feasibility and antitumor activity of sequential FOLFIRINOX and Stereotactic Body Radiotherapy (SBRT) in patients with locally advanced pancreatic cancer (LAPC), (LAPC-1 trial). METHODS: Patients with biopsy-proven LAPC treated in...
Autores principales: | Suker, Mustafa, Nuyttens, Joost J., Eskens, Ferry A.L.M., Haberkorn, Brigitte C.M., Coene, Peter-Paul L.O., van der Harst, Erwin, Bonsing, Bert A., Vahrmeijer, Alexander L., Mieog, J.Sven D., Jan Swijnenburg, Rutger, Roos, Daphne, Koerkamp, B.Groot., van Eijck, Casper H.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933188/ https://www.ncbi.nlm.nih.gov/pubmed/31891135 http://dx.doi.org/10.1016/j.eclinm.2019.10.013 |
Ejemplares similares
-
FOLFIRINOX and radiotherapy for locally advanced pancreatic cancer: A cohort study
por: Suker, Mustafa, et al.
Publicado: (2018) -
The yield of chest computed tomography in patients with locally advanced pancreatic cancer
por: Suker, Mustafa, et al.
Publicado: (2020) -
Molecular targets for diagnostic and intraoperative imaging of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX treatment
por: Vuijk, F. A., et al.
Publicado: (2020) -
Towards new treatment options for renal cell carcinoma: development and clinical results of tivozanib, a selective VEGFR tyrosine kinase inhibitor
por: Eskens, Ferry ALM, et al.
Publicado: (2012) -
Treatment Response and Conditional Survival in Advanced Pancreatic Cancer Patients Treated with FOLFIRINOX: A Multicenter Cohort Study
por: van der Sijde, Fleur, et al.
Publicado: (2022)